Conflict of interest L. Brochez has been paid as a consultant by Abbott, Pfizer. J. Lambert has served as consultant and/or paid speaker for and/or participated in clinical trials sponsored by companies that manufacture drugs used for the treatment of psoriasis including Abbott, Celgene, Centocor, Janssen-Cilag, LEO Pharma, Pfizer (formerly Wyeth). The other authors declare no conflicts of interest.
A cross-sectional study on the prevalence of metabolic syndrome in psoriasis compared to psoriatic arthritis
Article first published online: 28 DEC 2012
© 2012 The Authors. Journal of the European Academy of Dermatology and Venereology © 2012 European Academy of Dermatology and Venereology
Journal of the European Academy of Dermatology and Venereology
Volume 28, Issue 4, pages 507–511, April 2014
How to Cite
Bostoen, J., Van Praet, L., Brochez, L., Mielants, H. and Lambert, J. (2014), A cross-sectional study on the prevalence of metabolic syndrome in psoriasis compared to psoriatic arthritis. Journal of the European Academy of Dermatology and Venereology, 28: 507–511. doi: 10.1111/jdv.12071
Funding sources The study has been financially supported by Abbott.
- Issue published online: 18 MAR 2014
- Article first published online: 28 DEC 2012
- Received: 6 August 2012; Accepted: 15 November 2012
This article has been cited by:
- 1Recognizing and managing comorbidities in psoriatic arthritis, Current Opinion in Rheumatology, 2015, 27, 2, 118, , ,